- Home
- RVPH vs SFHG Comparison
RVPH vs SFHG Comparison
Compare RVPH & SFHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- SFHG
- Stock Information
- Founded
- RVPH 2006
- SFHG 1993
- Country
- RVPH United States
- SFHG Hong Kong
- Employees
- RVPH N/A
- SFHG N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- SFHG Publishing
- Sector
- RVPH Health Care
- SFHG Consumer Discretionary
- Exchange
- RVPH Nasdaq
- SFHG Nasdaq
- Market Cap
- RVPH 18.1M
- SFHG 14.9M
- IPO Year
- RVPH N/A
- SFHG 2024
- Fundamental
- Price
- RVPH $0.68
- SFHG N/A
- Analyst Decision
- RVPH Strong Buy
- SFHG
- Analyst Count
- RVPH 6
- SFHG 0
- Target Price
- RVPH $4.50
- SFHG N/A
- AVG Volume (30 Days)
- RVPH 16.9M
- SFHG 62.3K
- Earning Date
- RVPH 11-13-2025
- SFHG 04-16-2025
- Dividend Yield
- RVPH N/A
- SFHG N/A
- EPS Growth
- RVPH N/A
- SFHG N/A
- EPS
- RVPH N/A
- SFHG N/A
- Revenue
- RVPH N/A
- SFHG $19,760,935.00
- Revenue This Year
- RVPH N/A
- SFHG N/A
- Revenue Next Year
- RVPH N/A
- SFHG N/A
- P/E Ratio
- RVPH N/A
- SFHG N/A
- Revenue Growth
- RVPH N/A
- SFHG 30.89
- 52 Week Low
- RVPH $0.25
- SFHG $0.55
- 52 Week High
- RVPH $4.28
- SFHG $24.00
- Technical
- Relative Strength Index (RSI)
- RVPH 65.12
- SFHG 35.03
- Support Level
- RVPH $0.29
- SFHG $0.64
- Resistance Level
- RVPH $0.86
- SFHG $0.71
- Average True Range (ATR)
- RVPH 0.07
- SFHG 0.04
- MACD
- RVPH 0.05
- SFHG -0.01
- Stochastic Oscillator
- RVPH 72.03
- SFHG 8.87
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About SFHG Samfine Creation Holdings Group Limited Ordinary Share
Samfine Creation Holdings Group Ltd operates through its subsidiaries. It is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. It offers a wide range of printed products such as (i) book products, which mainly include children's books, educational books, art books, notebooks, diaries and journals; and (ii) novelty and packaging products, which mainly include handcraft products, book sets, pop-up books, stationery products, products with assembly parts and other specialized products, shopping bags and package boxes.